Suchergebnisse - "Gangadhar, Tara C"

PubPharm (70)

1

FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA : Preliminary Results From a Phase I/II Clinical Treatment Trial

enthalten in: Retina (Philadelphia, Pa.) | 2019

von Nti, A. | Serrano, L. | Sandhu, H. | +13

2

Correction : Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Joseph, R. | Elassaiss-Schaap, J. | Kefford, R. | +19

ErratumFor: Clin Cancer Res. 2018 Oct 15;24(20):4960-4967. - PMID 29685882

3

Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Joseph, R. | Elassaiss-Schaap, J. | Kefford, R. | +19

CommentIn: Clin Cancer Res. 2018 Oct 15;24(20):4915-4917. - PMID 29903895

4

Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Robert, C. | Ribas, A. | Hamid, O. | +17

CommentIn: J Clin Oncol. 2018 Jun 10;36(17):1649-1653. - PMID 29389234

5

Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma

enthalten in: Pigment cell & melanoma research | 2018

von Gangadhar, T. | Savitch, S. | Yee, S. | +20

6

Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma

enthalten in: Oncoimmunology | 2018

von Bajor, D. | Mick, R. | Riese, M. | +15

7

A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Yam, C. | Xu, X. | Davies, M. | +18

8

Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma

enthalten in: JAMA oncology | 2018

von Sinnamon, A. | Neuwirth, M. | Gimotty, P. | +4

CommentIn: JAMA Oncol. 2018 Aug 1;4(8):1136-1137. - PMID 29902301

9

Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines

enthalten in: Cell reports | 2017

von Garman, B. | Anastopoulos, I. | Krepler, C. | +31

10

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

enthalten in: Cell reports | 2017

von Krepler, C. | Sproesser, K. | Brafford, P. | +51

1
2
3
4
5
6
7
Nächster »
[7]